Shares of scientific instrument company Bruker (NASDAQ:BRKR). jumped 4.7% in the morning session after a company it ...

Investors may be wondering whether Bruker is quietly turning into a value opportunity, or if the recent noise is just a distraction from deeper issues in the business. The stock has bounced 6.8% over ...

In recent days, AbCellera and Bruker resolved their global patent dispute, with Bruker agreeing to pay US$36 million upfront plus ongoing royalties on Beacon Optofluidic platform sales. At the same ...

Bruker faced a tough 2024, with aggressive M&A, $600M preferred issuance, rising debt, and execution issues prompting a ...

On Monday, Bruker BRKR reached a key technical benchmark, with its Relative Strength (RS) Rating rising into the 80-plus ...

Wondering if Bruker is quietly turning into a bargain, or if there is a value trap hiding behind the ticker? Let us unpack what the recent share moves and fundamentals are really telling us. Bruker ...

AbCellera has reached a settlement and patent-license agreement to resolve patent litigation with Bruker Corporation. The biotechnology company said Thursday that it will receive a $36 million payment ...

Bruker Corporation (Nasdaq: BRKR) today announced several significant European orders for high-performance magnetic resonance ...

In the third quarter of 2025, Bruker reported adjusted earnings per share of US$0.45, topping estimates even as earnings fell 25% year over year. The company simultaneously cut its full-year 2025 ...

RI Research Instruments, a company that is majority-owned by Bruker Corporation (Nasdaq: BRKR), today announced orders for key components and enabling subsystems for the research gamma ray source of ...

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker today announced that it has acquired Nion, a privately-held company that develops and manufactures innovative high-end scanning transmission electron ...

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools, for ...